This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Novo Nordisk A/s. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Copenhagen, DE (2018)
- Copenhagen, DK (2020)
Company Filing History:
Years Active: 2018-2020
Title: The Innovations of Rune Viig Overgaard
Introduction
Rune Viig Overgaard is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of anti-KIR antibodies. With a total of 2 patents to his name, Overgaard's work is paving the way for advancements in cancer treatment.
Latest Patents
Overgaard's latest patents focus on anti-KIR antibodies, specifically a novel IgG4 isotype anti-KIR antibody. These patents detail innovative formulations and methods for using these antibodies. The patents also describe compositions, formulations, dosages, and administration regimens that are suitable for natural killer (NK) cell activation and therapeutic applications. Additionally, the patents include kits that comprise one or more anti-KIR antibodies, complete with instructions for use in treating cancer.
Career Highlights
Rune Viig Overgaard is currently associated with Novo Nordisk A/S, a leading global healthcare company. His work at Novo Nordisk emphasizes the importance of research and development in the biotechnology sector. Overgaard's contributions are instrumental in advancing therapeutic options for patients.
Collaborations
Overgaard collaborates with esteemed colleagues such as Peter Andreas Nicolai Reumert Wagtmann and Ivan Svendsen. These partnerships enhance the research efforts and innovation within the field.
Conclusion
Rune Viig Overgaard's innovative work in the development of anti-KIR antibodies represents a significant advancement in cancer treatment. His contributions to biotechnology are noteworthy and continue to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile